Search

Politicians are great gamblers – but the EC President is playing for high stakes by wagering all on the creation of a European Institute of Technology.

What is the DTI's Technology Strategy Board for? One answer comes in this week's UK budget.

Deloitte's take on the budget and R&D tax relief. And other responses on the spending for science.

The latest stop for the Science|Business road show had leading lights in EU policy arguing about what it takes to create a European innovation zone.

Its government will increase science spending by 25 per cent in the next three years – but the UK won’t meet the 3 per cent Lisbon target.

A draft European law to fight counterfeiting and piracy has been narrowed to exclude patent infringements – but many other legitimate activities look set to be criminalised.

Microsoft’s Jean-Philippe Courtois thinks Europe is an innovative place. But, he says, there are some clear gaps.

Is MIT really that special? Does it have lessons for others? A recent paper says that you have to line up a bunch of related factors – scientific, organisational, regional and so on. Picking them off one at a time won’t work.

A tale of two cities: as the industry in Lyon trumpeted the benefits of biotech, MEPs in Strasbourg looked the other way, and declined to debate them

The Finnish nanotechnology industry is in a boom phase, with the number of companies involved in the sector growing by 111 per cent in the past two years.

It’s easy to produce papers and make recommendations, says former Finnish prime minister Esko Aho. Now we need practical results.

YouTube, MySpace – those are some of the hottest properties on the Internet these days. They may also be the working definition of demand-side innovation,

European pharma and biotech companies are behind the US. But in one shining area, Europe has outpaced the US in creating a new sector: biosimilars.

The latest buzzword among Brussels technocrats is “lead markets”. And it’s going to be put into action, on an experimental basis, in 2007.